Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein. - Tseng JR; Hsu CL; Hsieh HH; Ho KC; Wu CY; Lin KH; Chung YH; Weng CC (EJNMMI research, 2026)